Journal profile · Infectious Diseases
Journal of Antimicrobial Chemotherapy
ISSN 0305-7453 · eISSN 1460-2091 · Oxford University Press · ENGLAND · Monthly · Founded 1975
Journal of Antimicrobial Chemotherapy: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.08; hybrid open access; APC about USD 3,784; median 133 days to acceptance (88 articles, last 24 months); community-reported acceptance: fairly hard; 509 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Journal of Antimicrobial Chemotherapy is published by Oxford University Press and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy and Antimicrobial Resistance in Staphylococcus, together about 42.8% of its articles. Its main subfields are Infectious Diseases. (generated from OpenAlex topic counts and CAS ranking data)
The Journal publishes articles that further knowledge and advance the science and application of antimicrobial chemotherapy with antibiotics and antifungal, antiviral and antiprotozoal agents. The Journal publishes primarily in human medicine, and articles in veterinary medicine likely to have an impact on global health.
Source: LetPub
Research area (LetPub): Infectious Diseases
Main research topics OpenAlex counts of recent articles; shares are approximate
- Antibiotic Resistance in BacteriaBiochemistry, Genetics and Molecular Biology18%
- Antibiotics Pharmacokinetics and EfficacyMedicine15.5%
- Antimicrobial Resistance in StaphylococcusMedicine9.2%
- Pneumonia and Respiratory InfectionsMedicine5.9%
- Antibiotic Use and ResistanceImmunology and Microbiology5.6%
- Bacterial Identification and Susceptibility TestingBiochemistry, Genetics and Molecular Biology5.2%
- HIV/AIDS drug development and treatmentMedicine3.8%
- Antifungal resistance and susceptibilityMedicine3.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Microbiology | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Microbiology | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 1 |
| Minor | Infectious Diseases | Zone 2 |
| Minor | Microbiology | Zone 2 |
Top journal: yesReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.08LetPub ·
- CiteScore 2026-06
- 6.6LetPub ·
- SJR 2026-06
- 1.26LetPub ·
- SNIP 2026-06
- 1.22LetPub ·
- h-index
- 172LetPub ·
- h-index
- 269OpenAlex ·
- i10-index
- 15,088OpenAlex ·
- 2-year mean citedness
- 4.25OpenAlex ·
- Self-citation rate
- 7.3%LetPub ·
- Share of gold OA articles
- 39.24%LetPub ·
Volume
- Articles per year
- 413LetPub ·
Articles by year OpenAlex count · 22,289 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 332 | 152 | 160 |
| 2025 | 509 | 241 | 1,660 |
| 2024 | 478 | 337 | 3,788 |
| 2023 | 416 | 314 | 4,831 |
| 2022 | 438 | 229 | 6,637 |
| 2021 | 502 | 284 | 9,652 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
133 daysMedian, submission to acceptance · P25–P75 86 days – 172 days
- Acceptance to online
- —
- Submission to online
- —
- Sample
- 88 articles with submission and acceptance dates (1,021 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 2–4 weeksLetPub ·
- Average acceptance (community reports)
- Fairly hardLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | GBP 2,869 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Oxford University Press
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Monthly
- Founded
- 1975
- ISSN
- 0305-7453
- Electronic ISSN
- 1460-2091
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Journal of Antimicrobial Chemotherapy
What CAS zone is Journal of Antimicrobial Chemotherapy in?
In the 2025 upgraded edition of the CAS Journal Ranking, Journal of Antimicrobial Chemotherapy is in Zone 2 of Medicine, and in Zone 2 of the minor category Infectious Diseases / Microbiology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Journal of Antimicrobial Chemotherapy?
The latest impact factor listed by LetPub is 4.08; CiteScore 6.6, h-index 269.
How long does peer review take at Journal of Antimicrobial Chemotherapy?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 133 days (interquartile range 86–172 days); authors report an average review time of 2–4 weeks; the community-reported acceptance is “Fairly hard”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Journal of Antimicrobial Chemotherapy?
According to LetPub and DOAJ records, Journal of Antimicrobial Chemotherapy is indexed in SCIE and Scopus.
Is Journal of Antimicrobial Chemotherapy open access, and what is the APC?
Journal of Antimicrobial Chemotherapy is a hybrid journal. For open-access publication: APC about USD 3,784.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .